Nate Crossett

Stock Analyst at Exane BNP Paribas

(2.36)
# 2,473
Out of 4,711 analysts
37
Total ratings
48%
Success rate
0.05%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Jul 2, 2024
Downgrades: Neutral
Price Target: $6$4
Current: $3.86
Upside: +3.63%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $37.83
Upside: -20.70%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $70.17
Upside: -8.79%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $14.16
Upside: +20.06%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $52.79
Upside: +19.34%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $99.17
Upside: +8.90%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $58.76
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $178.57
Upside: -22.72%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $103.32
Upside: +36.47%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $47.08
Upside: +33.81%
Initiates: Underperform
Price Target: $42
Current: $40.35
Upside: +4.09%
Initiates: Outperform
Price Target: $41
Current: $28.79
Upside: +42.41%
Initiates: Outperform
Price Target: $29
Current: $31.53
Upside: -8.02%
Initiates: Underperform
Price Target: $74
Current: $54.25
Upside: +36.41%
Initiates: Outperform
Price Target: n/a
Current: $19.51
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.15
Upside: +34.27%
Initiates: Outperform
Price Target: $66
Current: $105.10
Upside: -37.20%
Initiates: Outperform
Price Target: $38
Current: $21.48
Upside: +76.91%
Initiates: Outperform
Price Target: $886
Current: $927.22
Upside: -4.45%
Downgrades: Hold
Price Target: $31$30
Current: $27.16
Upside: +10.46%
Initiates: Buy
Price Target: $21
Current: $5.09
Upside: +312.57%
Downgrades: Hold
Price Target: $21$25
Current: $10.54
Upside: +137.19%
Upgrades: Buy
Price Target: n/a
Current: $19.80
Upside: -